Literature DB >> 23041674

Epigenetics in inflammatory bowel disease.

Andreas C Jenke1, Matthias Zilbauer.   

Abstract

PURPOSE OF REVIEW: To briefly summarize some of the principles of epigenetics and assess their potential relevance for the disease pathogenesis of inflammatory bowel diseases (IBDs). To review the results of recent IBD-related epigenetic studies, discuss main challenges as well as highlight the opportunities for future research in this field. RECENT
FINDINGS: Evidence is accumulating for a major role of epigenetic mechanisms in the disease pathogenesis of several immune-mediated diseases. Recent findings indicate that epigenetics may mediate some of the effects of environment, genetic predisposition and intestinal microbiota on IBD pathogenesis.
SUMMARY: Epigenetics is a rapidly expanding and hugely promising area of research. At best, it may provide a unifying molecular mechanism to explain complex immune-mediated diseases such as IBD. Future research studies must be carefully designed, performed and analysed taking into account the basic principles of epigenetics in order to ensure the true potential of this field is realized in the understanding of IBD.

Entities:  

Mesh:

Year:  2012        PMID: 23041674     DOI: 10.1097/MOG.0b013e328357336b

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  18 in total

Review 1.  Epigenetics and innate immunity: the 'unTolld' story.

Authors:  Conor Hennessy; Declan P McKernan
Journal:  Immunol Cell Biol       Date:  2016-02-29       Impact factor: 5.126

Review 2.  Determinants of IBD Heritability: Genes, Bugs, and More.

Authors:  Williams Turpin; Ashleigh Goethel; Larbi Bedrani; Kenneth Croitoru Mdcm
Journal:  Inflamm Bowel Dis       Date:  2018-05-18       Impact factor: 5.325

3.  TP53 codon 72 Arg/Arg polymorphism is associated with a higher risk for inflammatory bowel disease development.

Authors:  Natalia Volodko; Mohamed Salla; Bertus Eksteen; Richard N Fedorak; Hien Q Huynh; Shairaz Baksh
Journal:  World J Gastroenterol       Date:  2015-09-28       Impact factor: 5.742

Review 4.  Epigenetics: the fine-tuner in inflammatory bowel disease?

Authors:  Eleni Stylianou
Journal:  Curr Opin Gastroenterol       Date:  2013-07       Impact factor: 3.287

5.  Epigenetic control of intestinal barrier function and inflammation in zebrafish.

Authors:  Lindsay Marjoram; Ashley Alvers; M Elizabeth Deerhake; Jennifer Bagwell; Jamie Mankiewicz; Jordan L Cocchiaro; Rebecca W Beerman; Jason Willer; Kaelyn D Sumigray; Nicholas Katsanis; David M Tobin; John F Rawls; Mary G Goll; Michel Bagnat
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-17       Impact factor: 11.205

Review 6.  Mucosal healing and deep remission: what does it mean?

Authors:  Gerhard Rogler; Stephan Vavricka; Alain Schoepfer; Peter L Lakatos
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

Review 7.  Microbiome-Epigenome Interactions and the Environmental Origins of Inflammatory Bowel Diseases.

Authors:  Tatiana Y Fofanova; Joseph F Petrosino; Richard Kellermayer
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-02       Impact factor: 2.839

Review 8.  Epigenetic enzymes are the therapeutic targets for CD4(+)CD25(+/high)Foxp3(+) regulatory T cells.

Authors:  Jahaira Lopez-Pastrana; Ying Shao; Valeria Chernaya; Hong Wang; Xiao-Feng Yang
Journal:  Transl Res       Date:  2014-08-15       Impact factor: 7.012

Review 9.  Stem Cells in Repair of Gastrointestinal Epithelia.

Authors:  Amanda Andersson-Rolf; Matthias Zilbauer; Bon-Kyoung Koo; Hans Clevers
Journal:  Physiology (Bethesda)       Date:  2017-07

10.  Trichostatin A promotes the generation and suppressive functions of regulatory T cells.

Authors:  Cristian Doñas; Macarena Fritz; Valeria Manríquez; Gabriela Tejón; María Rosa Bono; Alejandra Loyola; Mario Rosemblatt
Journal:  Clin Dev Immunol       Date:  2013-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.